- Investing Ideas
- /
- Japanese Biotech Stocks
Japanese Biotech Stocks
Results
51
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
51 companies
Takeda Pharmaceutical
Market Cap: JP¥8.0t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,080.00
7D
5.1%
1Y
23.3%
Daiichi Sankyo Company
Market Cap: JP¥6.6t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,542.00
7D
5.8%
1Y
-14.2%
Otsuka Holdings
Market Cap: JP¥4.8t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥9,090.00
7D
2.4%
1Y
12.7%
Astellas Pharma
Market Cap: JP¥4.0t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,236.50
7D
6.9%
1Y
48.1%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,907.00
7D
2.3%
1Y
29.0%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.
4151
JP¥2,571.00
7D
1.7%
1Y
12.3%
Eisai
Market Cap: JP¥1.3t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.
4523
JP¥4,767.00
7D
2.3%
1Y
11.9%
Sumitomo Pharma
Market Cap: JP¥1.2t
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥2,909.50
7D
25.5%
1Y
437.8%
Santen Pharmaceutical
Market Cap: JP¥506.0b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,676.50
7D
3.1%
1Y
9.0%
Hisamitsu Pharmaceutical
Market Cap: JP¥451.3b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥6,441.00
7D
46.7%
1Y
38.3%
Nippon Shinyaku
Market Cap: JP¥382.5b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥5,675.00
7D
0.4%
1Y
43.4%
Tsumura
Market Cap: JP¥311.2b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥4,187.00
7D
2.7%
1Y
-10.1%
Sawai Group Holdings
Market Cap: JP¥277.2b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥2,400.00
7D
1.7%
1Y
9.9%
PeptiDream
Market Cap: JP¥224.2b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,735.00
7D
4.7%
1Y
-26.1%
Kissei Pharmaceutical
Market Cap: JP¥198.1b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,780.00
7D
2.8%
1Y
16.7%
Towa Pharmaceutical
Market Cap: JP¥178.2b
Manufactures and sale ethical drugs in Japan.
4553
JP¥3,620.00
7D
-0.5%
1Y
9.7%
GNI Group
Market Cap: JP¥137.3b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,466.00
7D
2.2%
1Y
-20.1%
Takara Bio
Market Cap: JP¥98.7b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥820.00
7D
3.1%
1Y
-17.8%
Zeria Pharmaceutical
Market Cap: JP¥93.1b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,113.00
7D
0.7%
1Y
-6.1%
KYORIN Pharmaceutical
Market Cap: JP¥91.9b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,599.00
7D
4.0%
1Y
10.0%
Nxera Pharma
Market Cap: JP¥78.7b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥870.00
7D
5.2%
1Y
-11.8%
Shin Nippon Biomedical Laboratories
Market Cap: JP¥68.4b
A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.
2395
JP¥1,643.00
7D
-1.7%
1Y
-1.6%
ASKA Pharmaceutical HoldingsLtd
Market Cap: JP¥59.7b
Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.
4886
JP¥2,101.00
7D
3.1%
1Y
5.2%
Fuji Pharma
Market Cap: JP¥46.8b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,912.00
7D
1.3%
1Y
26.0%
3-D Matrix
Market Cap: JP¥42.3b
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.
7777
JP¥352.00
7D
-1.9%
1Y
125.6%
Daito PharmaceuticalLtd
Market Cap: JP¥40.2b
Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.
4577
JP¥1,363.00
7D
0.5%
1Y
36.6%
Seikagaku
Market Cap: JP¥39.7b
Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.
4548
JP¥727.00
7D
2.3%
1Y
-6.8%
Japan Tissue Engineering
Market Cap: JP¥22.0b
Engages in the regenerative medicine business in Japan.
7774
JP¥542.00
7D
-12.9%
1Y
14.6%
Fuso Pharmaceutical IndustriesLtd
Market Cap: JP¥20.2b
Manufactures and sells pharmaceuticals and medical equipment in Japan.
4538
JP¥2,369.00
7D
2.3%
1Y
-2.9%
Pharma Foods International
Market Cap: JP¥19.7b
Engages in the development and sale of functional food ingredients in Japan.
2929
JP¥683.00
7D
0.6%
1Y
-31.1%
Astena Holdings
Market Cap: JP¥19.6b
Manufactures and sells medicine-related products in Japan.
8095
JP¥485.00
7D
0.4%
1Y
6.4%
StemRIM
Market Cap: JP¥17.5b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥279.00
7D
6.1%
1Y
-9.7%
Kidswell Bio
Market Cap: JP¥11.6b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥234.00
7D
15.3%
1Y
120.8%
CellSource
Market Cap: JP¥8.3b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥421.00
7D
5.5%
1Y
-49.3%
OncoTherapy Science
Market Cap: JP¥8.2b
Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.
4564
JP¥24.00
7D
20.0%
1Y
4.3%
Chordia Therapeutics
Market Cap: JP¥8.1b
A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.
190A
JP¥118.00
7D
9.3%
1Y
-67.1%